Clinicopathological significance of vascular endothelial growth factor, thymidine phosphorylase and microvessel density in colorectal cancer

Clinicopathological significance of vascular endothelial growth factor, thymidine phosphorylase and microvessel density in colorectal cancer

Colorectal cancer is a common malignant disease, the incidence of which is increasing worldwide, therefore, identifying novel prognostic factors to improve adjuvant therapeutic strategies or postoperative monitoring is required. Angiogenesis, which is assessed by microvessel density (MVD), is signif...

Full description

Bibliographic Details
Main Authors:	KIMURA, YUTAKA, MOROHASHI, SATOKO, YOSHIZAWA, TADASHI, SUZUKI, TAKAHIRO, MOROHASHI, HAJIME, SAKAMOTO, YOSHIYUKI, KOYAMA, MOTOI, MURATA, AKIHIKO, KIJIMA, HIROSHI, HAKAMADA, KENICHI
Format:	Online
Language:	English
Published:	D.A. Spandidos 2016
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4732825/

Similar Items

Myofibroblasts of the muscle layer stimulate the malignant potential of colorectal cancer
by: Takatsuna, Masafumi, et al.
Published: (2016)

A new histological therapeutic classification system to predict eradicated and residual lymph nodes in breast cancer after neoadjuvant chemotherapy
by: MOROHASHI, SATOKO, et al.
Published: (2016)

Basic helix-loop-helix transcription factor DEC2 functions as an anti-apoptotic factor during paclitaxel-induced apoptosis in human prostate cancer cells
by: Liu, Qiang, et al.
Published: (2016)

Invasive micropapillary carcinoma of the extrahepatic bile duct and its malignant potential
by: YOSHIZAWA, TADASHI, et al.
Published: (2014)

Podoplanin-mediated TGF-β-induced epithelial-mesenchymal transition and its correlation with bHLH transcription factor DEC in TE-11 cells
by: WU, YUNYAN, et al.
Published: (2016)

Expression of Thymidine Phosphorylase in Lymph Nodes Involved with Mycosis Fungoides and Sézary Syndrome
by: Nie, Xingcao, et al.
Published: (2011)

Research development of the relationship between thymidine phosphorylase expression and colorectal carcinoma
by: Ye, Dian-Jun, et al.
Published: (2013)

Erratum to research development of the relationship between thymidine phosphorylase expression and colorectal carcinoma
by: Ye, Dian-Jun, et al.
Published: (2013)

Thymidine Phosphorylase Gene Expression in Stage III Colorectal Cancer
by: Lindskog, Elinor B., et al.
Published: (2012)

Liver as a Source for Thymidine Phosphorylase Replacement in Mitochondrial Neurogastrointestinal Encephalomyopathy
by: Boschetti, Elisa, et al.
Published: (2014)

Thymidine phosphorylase expression is associated with time to progression in patients with metastatic colorectal cancer
by: Lindskog, Elinor Bexe, et al.
Published: (2014)

Biochemical abnormalities in a patient with thymidine phosphorylase deficiency with fatal outcome
by: Bakker, Jaap A., et al.
Published: (2010)

Possible role of thymidine phosphorylase in gynecological tumors as an individualized treatment strategy
by: Shida, Masako, et al.
Published: (2016)

Correction: Liver as a Source for Thymidine Phosphorylase Replacement in Mitochondrial Neurogastrointestinal Encephalomyopathy
Published: (2014)

4-Methylumbelliferone inhibits ovarian cancer growth by suppressing thymidine phosphorylase expression
by: Tamura, Ryosuke, et al.
Published: (2014)

Fatty acid synthase-positive hepatocytes and subsequent steatosis in rat livers by irinotecan
by: SAWANO, TAKEYUKI, et al.
Published: (2015)

Myofibroblast distribution is associated with invasive growth types of colorectal cancer
by: Takatsuna, Masafumi, et al.
Published: (2016)

Imaging hamster model of bile duct cancer in vivo using fluorescent l-glucose derivatives
by: Yokoyama, Hiroshi, et al.
Published: (2016)

Incidental prostate 18F-FDG uptake without calcification indicates the possibility of prostate cancer
by: SEINO, HIROKO, et al.
Published: (2014)

Hypoxia is important in F-18 FDG accumulation in thecoma-fibroma tumors on F-18 FDG PET/CT scans
by: SEINO, HIROKO, et al.
Published: (2016)

Thymidine phosphorylase mRNA expression may be a predictor of response to post-operative adjuvant chemotherapy with S-1 in patients with stage III colorectal cancer
by: OGAWA, MASAICHI, et al.
Published: (2014)

Association of tumour necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma.
by: Leek, R. D., et al.
Published: (1998)

Expression of thymidine phosphorylase in peripheral blood cells of breast cancer patients is not increased by paclitaxel
by: Bartsch, Rupert, et al.
Published: (2007)

Differential expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human lung carcinoma cell lines.
by: Heldin, N. E., et al.
Published: (1993)

Platelet-derived endothelial cell growth factor thymidine phosphorylase in tumour growth and response to therapy.
by: Griffiths, L., et al.
Published: (1997)

Thymidine phosphorylase in cancer cells stimulates human endothelial cell migration and invasion by the secretion of angiogenic factors
by: Bijnsdorp, I V, et al.
Published: (2011)

Thymidine phosphorylase/platelet-derived endothelial cell growth factor expression associated with hepatic metastasis in gastric carcinoma.
by: Maeda, K., et al.
Published: (1996)

The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium.
by: Fox, S. B., et al.
Published: (1996)

The Sp1 transcription factor is essential for the expression of gliostatin/thymidine phosphorylase in rheumatoid fibroblast-like synoviocytes
by: Ikuta, Kenji, et al.
Published: (2012)

Interferon-α Enhances 5′-Deoxy-5-Fluorouridine-Induced Apoptosis by ERK-Dependant Upregulation of Thymidine Phosphorylase
by: Zhu, Yike, et al.
Published: (2013)

A possible role of thymidine phosphorylase expression and5-fluorouracil increased sensitivity in oropharyngeal cancer patients
by: Ranieri, G, et al.
Published: (2007)

Regulation and Novel Action of Thymidine Phosphorylase in Non-Small Cell Lung Cancer: Crosstalk with Nrf2 and HO-1
by: Tertil, Magdalena, et al.
Published: (2014)

Systemic immune-inflammation index, thymidine phosphorylase and survival of localized gastric cancer patients after curative resection
by: Huang, Liu, et al.
Published: (2016)

Can Thymidine Phosphorylase Be a Predictive Marker for Gemcitabine and Doxifluridine Combination Chemotherapy in Cholangiocarcinoma?: Case Series
by: Kang, Myoung Hee, et al.
Published: (2014)

Thymidine phosphorylase activates NFκB and stimulates the expression of angiogenic and metastatic factors in human cancer cells
by: Tabata, Sho, et al.
Published: (2014)

Thymidine phosphorylase gene variant, platelet counts and survival in gastrointestinal cancer patients treated by fluoropyrimidines
by: Huang, Liu, et al.
Published: (2014)

Valproic acid potentiates the anticancer activity of capecitabine in vitro and in vivo in breast cancer models via induction of thymidine phosphorylase expression
by: Terranova-Barberio, Manuela, et al.
Published: (2015)

Synthesis, in vitro evaluation of thymidine phosphorylase inhibitory activity, and in silico study of 1,3,5-triazin-2,4-dione and its fused analogues
by: Bera, H., et al.
Published: (2013)

Prognostic significance of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase protein expression in colorectal cancer patients treated with or without 5-fluorouracil-based chemotherapy
by: Soong, R., et al.
Published: (2008)

Synthesis and in vitro evaluation of 1,2,4-triazolo[1,5-a][1,3,5]triazine derivatives as thymidine phosphorylase inhibitors
by: Bera, H., et al.
Published: (2013)